Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Parallel Controlled Study of Epstein-Barr Virus Antibody and Epstein-Barr Virus DNA for Nasopharyngeal Carcinoma Screening in the High-risk Population

NCT05447169 is registered in ClinicalTrials.gov with Sun Yat-sen University as lead sponsor.

NCT NCT05447169
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05447169 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Parallel Controlled Study of Epstein-Barr Virus Antibody and Epstein-Barr Virus DNA for Nasopharyngeal Carcinoma Screening in the High-risk Population
Lead sponsor
Sun Yat-sen University
Phase
Observational
Overall status
Recruiting
Start date
July 10, 2022
Completion date
July 1, 2030
Enrollment
11,625 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

nasopharyngeal carcinoma